In addition, ACE inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and HCCs, because angiogenesis is an essential process in tumor growth and liver fibrosis. This evidence concerns the gene ACE and Hepatic fibrosis.